Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion type Assertion NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_head.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion description "[Of 182 unifocal primary HCCs, ANXA10 mRNA was dramatically reduced in 121 (66%), and the down-regulation correlated with p53 mutation (P = 0.024), early intrahepatic tumor recurrence (P = 0.0007), and lower 4-year survival (P = 0.0014).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_provenance.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion evidence source_evidence_literature NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_provenance.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion SIO_000772 12000734 NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_provenance.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion wasDerivedFrom befree-20140225 NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_provenance.
- NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_assertion wasGeneratedBy ECO_0000203 NP183186.RAt-2mgEr_SMKiQ7lkjct1MdeUQ5jRZKEicnPkDrNY1A4130_provenance.